Indication
Duzallo is indicated in adults for the treatment of hyperuricaemia in gout patients who have not achieved target serum uric acid levels with an adequate dose of allopurinol alone.
Loading your page…
Loading your page…
Gout
Marketing Authorisation Holder: Grunenthal GmbH
EMA Authorisation: 23/08/2018
INN: allopurinol;lesinurad
AI Drug & Interaction Analysis
Free account required
Ask Osler about Duzallo: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.